Ban Vu
Family Medicine · Westminster, CANPI 1043261936
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 154 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $5,351 and has fallen 57.1% since, to $2,294 in 2025. Among family medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 154 payments — averaging $107.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- Gilead$2K
- Lilly USA, LLC$2K
- AstraZeneca$2K
- Boehringer Ingelheim$1K
- AbbVie$793
- plus $6K from 29 others
What the payments were for
- Travel & lodging$20%
- Food & beverage$16,499100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 28 | $3,305 |
| Gilead | 15 | $1,809 |
| Lilly USA, LLC | 23 | $1,806 |
| AstraZeneca | 17 | $1,602 |
| Boehringer Ingelheim | 10 | $1,057 |
| AbbVie | 7 | $793 |
| Phathom Pharmaceuticals, Inc. | 6 | $742 |
| Abbott | 3 | $418 |
| GSK | 3 | $366 |
| Intercept Pharmaceuticals, Inc. | 3 | $359 |
| Johnson & Johnson | 3 | $310 |
| Insulet Corporation | 2 | $290 |
| Scilex Pharmaceuticals Inc. | 2 | $277 |
| Galderma Laboratories, L.p. | 2 | $269 |
| Redhill Biopharma Inc. | 3 | $260 |
| Novartis | 2 | $245 |
| LEO Pharma Inc. | 2 | $243 |
| Novo Nordisk | 2 | $240 |
| Corcept Therapeutics | 2 | $227 |
| Amarin Pharma, Inc. | 2 | $210 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $197 |
| Sanofi | 2 | $172 |
| Abiomed | 1 | $137 |
| Bristol Myers Squibb | 1 | $134 |
| Theratechnologies Inc. | 1 | $125 |
| Ardelyx, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $116 |
| Inari Medical, Inc. | 1 | $93 |
| UCB, Inc. | 1 | $79 |
| Covidien LP | 1 | $74 |
| Dexcom, Inc. | 1 | $41 |
| Orthofix Medical, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,502 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.
Other family medicine in Westminster
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
- Amira AyadBakersfield$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.